pyrazolanthrone has been researched along with Glucose Intolerance in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LH; Chen, V; De, SK; Karin, M; Kitada, S; Kuntzen, C; Machleidt, T; Pavlickova, P; Pellecchia, M; Stebbins, JL | 1 |
Bhatnagar, A; Conklin, DJ; Ghosh Dastidar, S; Haberzettl, P; Hill, BG; Jagatheesan, G; Shah, J | 1 |
2 other study(ies) available for pyrazolanthrone and Glucose Intolerance
Article | Year |
---|---|
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.
Topics: Adenosine Triphosphate; Amino Acid Motifs; Animals; Binding, Competitive; Cell Line; Chemical and Drug Induced Liver Injury; Consensus Sequence; Cytokines; Diabetes Mellitus, Type 2; Drug Design; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Mimicry; Peptides; Phosphorylation; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 2011 |
Glutathione S-transferase P deficiency induces glucose intolerance via JNK-dependent enhancement of hepatic gluconeogenesis.
Topics: Animals; Anthracenes; Body Composition; Gluconeogenesis; Glucose Intolerance; Glutathione Transferase; JNK Mitogen-Activated Protein Kinases; Liver; Mice; Mice, Knockout | 2018 |